美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元

市场透视12-03

北京时间2024年12月03日00时05分，美国OTC市场Calithera Biosciences Inc（CALA.us）股票出现波动，股价急速拉升29.87%。截至发稿，该股报0.010美元/股，成交量810股，换手率0.02%，振幅28.57%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.29百万美元，每股收益-4.60美元，毛利-1.39百万美元，市盈率-0.00倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2488603085?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-03 00:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2488603085","market":"us","top_or_hot":-1,"title":"美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月03日00时05分，美国OTC市场Calithera Biosciences Inc（CALA.us）股票出现波动，股价急速拉升29.87%。截至发稿，该股报0.010美元/股，成交量810股，换手率0.02%，振幅28.57%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.29百万美元，每股收益-4.60美元，毛利-1.39百万美元，市盈率-0.00倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场Calithera Biosciences Inc股价上涨29.87% 市值涨1.46万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-03 00:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月03日00时05分，美国OTC市场Calithera Biosciences Inc（CALA.us）股票出现波动，股价急速拉升29.87%。截至发稿，该股报0.010美元/股，成交量810股，换手率0.02%，振幅28.57%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.29百万美元，每股收益-4.60美元，毛利-1.39百万美元，市盈率-0.00倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b","article_id":"2488603085","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000502abf02fae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2488603085","pubTimestamp":1733155501,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月03日00时05分，美国OTC市场Calithera Biosciences Inc股票出现波动，股价急速拉升29.87%。截至发稿，该股报0.010美元/股，成交量810股，换手率0.02%，振幅28.57%。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.03%。美国OTC市场Calithera Biosciences Inc公司简介：Calithera Biosciences Inc是一家临床阶段的制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CALA":"Calithera Biosciences, Inc."},"translate_title":"Calithera Biosciences Inc stock rose 29.87% in the U.S. OTC market, and its market value rose by $14,600","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CALA":0.9},"content_text":"北京时间2024年12月03日00时05分，美国OTC市场Calithera Biosciences Inc（CALA.us）股票出现波动，股价急速拉升29.87%。截至发稿，该股报0.010美元/股，成交量810股，换手率0.02%，振幅28.57%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-21.29百万美元，每股收益-4.60美元，毛利-1.39百万美元，市盈率-0.00倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Calithera Biosciences Inc股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Cardio Diagnostics Holdings Inc C/Wts (01/12/2026) To Pur Com涨幅较大，Senti Biosciences, Inc.、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为1905.59%、246.08%、28.41%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Protagenic Therapeutics Inc C/Wts 29/04/2026 (To Pur Com)，振幅分别为481.02%、64.17%、61.05%。美国OTC市场Calithera Biosciences Inc公司简介：Calithera Biosciences Inc是一家临床阶段的制药公司。该公司的业务活动贯穿美国地区。研究重点是发现和开发针对肿瘤和控制肿瘤微环境中关键代谢途径的免疫细胞靶标的小分子药物。其主要候选产品是CB-839，一种治疗实体肿瘤的谷氨酰胺酶抑制剂。它的另一个候选产品CB-1158正在开发中，用于血液学和肿瘤学适应症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488603085"}